Acelrx Pharmaceuticals, Inc.:Acelrx Pharmaceuticals Inc (ACRX)
Acelrx Pharmaceuticals Inc (ACRX)
鉅亨美股頻道提供你最完整的ACRX-AcelrxPharmaceuticalsInc(ACRX)、美股公司資料、美股股票代號、美股新聞、股價走勢、技術線圖、財報分析、外資分析師評等、歷史 ...。其他文章還包含有:「Talphera」、「AcelrxPharmaceuticalsInc(ACRX)-市場」、「AcelRxPharmaceuticals」、「AcelRxPharmaceuticalsInc(R5XA.BE)股價、新聞」、「AcelRxPharmaceuticalsInc(R5XA.SG)股價、新聞」、「AcelRxbecomesTalphera」、「買賣AcelRxPh...
查看更多 離開網站Talphera
https://talphera.com
When we founded our company, formerly known as AcelRx Pharmaceuticals, our mission was to deliver innovative acute pain products to healthcare providers in ...
Acelrx Pharmaceuticals Inc (ACRX) - 市場
https://invest.cnyes.com
鉅亨美股頻道提供你最完整的ACRX - Acelrx Pharmaceuticals Inc (ACRX)、美股公司資料、美股股票代號、美股新聞、股價走勢、技術線圖、財報分析、外資分析師評等、歷史 ...
AcelRx Pharmaceuticals
https://www.moneydj.com
AcelRx Pharmaceuticals, Inc.(ACRX.US)成立於2005年,總部位於美國加州紅木城,前身為SuRx, Inc.,2006年8月更為現名,為一家專業製藥公司,開發及商品化 ...
AcelRx Pharmaceuticals Inc (R5XA.BE) 股價、新聞
https://hk.finance.yahoo.com
市值, 無. Beta 值(5 年,每月), 無. 市盈率(最近12 個月), 無. 每股盈利(最近12 個月), 無. 業績公佈日, 2024年11月11日. 遠期股息及收益率,無(無).
AcelRx Pharmaceuticals Inc (R5XA.SG) 股價、新聞
https://hk.finance.yahoo.com
市值, 無. Beta 值(5 年,每月), 無. 市盈率(最近12 個月), 無. 每股盈利(最近12 個月), 無. 業績公佈日, 2024年11月11日. 遠期股息及收益率,無(無).
AcelRx becomes Talphera
https://www.fiercepharma.com
AcelRx won approval in 2018 but failed to turn the opioid into a major product, generating sales of $1.8 million in 2022. Alora Pharmaceuticals ...
買賣AcelRx Pharmaceuticals Inc 股票
https://www.ig.com
Talphera, Inc., formerly AcelRx Pharmaceuticals, Inc., is a specialty pharmaceutical company. The Company is focused on the development and... [CN]
Talphera
https://www.linkedin.com
Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised ...
AcelRx Announces Rebranding With Name Change to ...
https://ir.talphera.com
Name change to Talphera reflects a new era of the Company in partnership with the medical community developing novel solutions for medically supervised ...